Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Enterprise Value: 2009-2025

Historic Enterprise Value for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to -$45.2 million.

  • Nutex Health's Enterprise Value fell 6386.82% to -$45.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.2 million, marking a year-over-year decrease of 6386.82%. This contributed to the annual value of $12.5 million for FY2024, which is 38771.21% up from last year.
  • According to the latest figures from Q3 2025, Nutex Health's Enterprise Value is -$45.2 million, which was down 6386.82% from $4.9 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Enterprise Value ranged from a high of $85.7 million in Q3 2021 and a low of -$45.2 million during Q3 2025
  • Moreover, its 5-year median value for Enterprise Value was -$12.5 million (2022), whereas its average is -$5.9 million.
  • Over the last 5 years, Nutex Health's Enterprise Value had its largest YoY gain of 30891020.83% in 2021, and its largest YoY loss of 1109658.46% in 2021.
  • Over the past 5 years, Nutex Health's Enterprise Value (Quarter) stood at $40.8 million in 2021, then plummeted by 123.99% to -$9.8 million in 2022, then surged by 55.58% to -$4.3 million in 2023, then skyrocketed by 387.71% to $12.5 million in 2024, then tumbled by 461.07% to -$45.2 million in 2025.
  • Its last three reported values are -$45.2 million in Q3 2025, $4.9 million for Q2 2025, and -$9.4 million during Q1 2025.